Difference between revisions of "HEG1"

HEG1 (view source)

13 bytes added , 15:56, 15 September 2025

no edit summary

49,294

edits

Revision as of 15:55, 15 September 2025 (view source) Michael (talk \| contribs) ← Older edit		Latest revision as of 15:56, 15 September 2025 (view source) Michael (talk \| contribs)
Line 1:		Line 1:
	'''HEG1''' is an [[immunostain]] ~~positive~~ in [[malignant mesothelioma]].<ref name=pmid28361969>{{cite journal \|authors=Tsuji S, Washimi K, Kageyama T, Yamashita M, Yoshihara M, Matsuura R, Yokose T, Kameda Y, Hayashi H, Morohoshi T, Tsuura Y, Yusa T, Sato T, Togayachi A, Narimatsu H, Nagasaki T, Nakamoto K, Moriwaki Y, Misawa H, Hiroshima K, Miyagi Y, Imai K \|title=HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma \|journal=Sci Rep \|volume=7 \|issue= \|pages=45768 \|date=March 2017 \|pmid=28361969 \|doi=10.1038/srep45768 \|url=}}</ref>		'''HEG1''' is an [[immunostain]] used in the diagnosis of [[malignant mesothelioma]].<ref name=pmid28361969>{{cite journal \|authors=Tsuji S, Washimi K, Kageyama T, Yamashita M, Yoshihara M, Matsuura R, Yokose T, Kameda Y, Hayashi H, Morohoshi T, Tsuura Y, Yusa T, Sato T, Togayachi A, Narimatsu H, Nagasaki T, Nakamoto K, Moriwaki Y, Misawa H, Hiroshima K, Miyagi Y, Imai K \|title=HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma \|journal=Sci Rep \|volume=7 \|issue= \|pages=45768 \|date=March 2017 \|pmid=28361969 \|doi=10.1038/srep45768 \|url=}}</ref>

	==Use==		==Use==